California’s mental health commission on Thursday announced its executive director would resign amid revelations that he traveled to the U.K. courtesy of a state vendor while he sought to prevent a budget cut that would have defunded the company’s contract. Toby Ewing, executive director of the Mental Health Services Oversight and Accountability Commission, will step down effective ...

More than half of insured Americans say they can’t predict how much their covered prescription drugs will cost, according to an annual survey by the pharmaceutical industry trade group PhRMA. Why it matters: The results, shared first with Axios, come as the drug industry is pressing for more transparency regulations on pharmacy benefit managers and insurers in the lame-duck ...

CMS payment model changes, rising costs and higher utilization. In addition to these Medicare Advantage (MA) stories, which have dominated 2024, the past few weeks have been a cornucopia of new headlines. Their alternate versions might read: When stock value trumps vision. The ouster of CEO Karen Lynch at CVS Health, the possible break-up of its business ...

Walmart plans to expand its home delivery of pharmacy items and offer them alongside the other merchandise in its online store, spreading to virtually all U.S. states in the next few months, the retailer announced. The new policy applies to same-day delivery of prescription medications and has already been rolled out to six states: Arkansas, ...

Technology is constantly evolving, and one of the industries where it’s having the greatest impact is insurance. If you’re a health insurance agent or broker, you need to keep up on how tech can impact you, your clients, underwriting new business, transparency, health monitoring, and policy personalization. Below is a look at five of the ...

Federal regulators are confronting a new twist in drug development: manufacturers that include software with the medicine to prod patients to take pills as directed, manage side effects or track how well a treatment works. Why it matters: The apps could boost the drugs’ clinical value and provide a more personalized approach to managing chronic conditions ...